ArticleJournal of medical systems2026
Building a Clinically Relevant and Technically Robust Synthetic Histopathology Dataset for Breast and Gastric Cancer.
Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Data scarcity, inter-institutional stain variability, and privacy constraints are major challenges impeding the development of generalizable artificial intelligence models in digital pathology. Although recent generative adversarial network (GAN)-based synthesis approaches show promise, they struggle to preserve fine-grained nuclear morphology or maintain class-specific histological diversity. Moreover, existing diffusion-based studies have not sufficiently addressed class-conditional synthesis across heterogeneous, multi-institutional pathology data. We introduce the Efficient Pathology Diffusion Pipeline (EPDP), a class-conditional diffusion framework that enables the generation of clinically relevant, subtype-specific synthetic histopathology images for training and validating diagnostic AI models. By providing high-fidelity, subtype-specific synthetic datasets, EPDP lowers the barriers to developing robust AI diagnostic tools and supports the establishment of standardized evaluation frameworks in digital pathology. To achieve this, EPDP integrates a customized denoising U-Net that employs nuclear details, learnable class embeddings, and CycleGAN-based stain normalization with reference-guided alignment. This design explicitly targets the preservation of fine-grained nuclear morphology, class-specific histological diversity, and stain-invariant visual consistency across institutions. Multi-institutional hematoxylin and eosin whole-slide images are curated via a two-round pathology review to build subtype-labeled training and evaluation sets. Image fidelity is assessed using FID, 1-LPIPS, and SSIM, and compared against state-of-the-art models including PathDiff, PathLDM, and DiffInfinite. Diagnostic utility was evaluated using cross-domain classification (EfficientNetV2-L), and perceptual realism was assessed using a visual Turing test (VTT). The real-synthetic FID was lower than that of real-real FID by 11.0% (breast) and 8.6% (gastric). The subtype 1-LPIPS gaps were ≤ 12%, and the SSIM gaps were ≤ 0.3%. Classifiers trained only on synthetic patches matched real-trained baselines within an ~ 1% F1 score on real-image validation. Pathologists performed at near-chance levels in the VTT, with accuracies ranging from 50% to 56%.
Indexed as
Identifiers
42310241What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.